Old drug provides promising new avenue for treatment of MND

An international study led by biochemists at the University of Liverpool has shown that the drug-molecule ebselen can correct many of the toxic characteristics of a protein that causes some cases of hereditary motor neurone disease (MND).

Go to Source

(Visited 6 times, 1 visits today)

Site Footer

Sliding Sidebar